Taylor Morrison Home Statistics
Total Valuation
TMHC has a market cap or net worth of $6.03 billion. The enterprise value is $7.83 billion.
Market Cap | 6.03B |
Enterprise Value | 7.83B |
Important Dates
The next confirmed earnings date is Wednesday, July 23, 2025, before market open.
Earnings Date | Jul 23, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TMHC has 100.37 million shares outstanding. The number of shares has decreased by -3.93% in one year.
Current Share Class | 100.37M |
Shares Outstanding | 100.37M |
Shares Change (YoY) | -3.93% |
Shares Change (QoQ) | -2.09% |
Owned by Insiders (%) | 0.63% |
Owned by Institutions (%) | 99.24% |
Float | 99.69M |
Valuation Ratios
The trailing PE ratio is 6.98 and the forward PE ratio is 7.78.
PE Ratio | 6.98 |
Forward PE | 7.78 |
PS Ratio | 0.74 |
Forward PS | 0.77 |
PB Ratio | 1.01 |
P/TBV Ratio | 1.15 |
P/FCF Ratio | 15.83 |
P/OCF Ratio | 14.48 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.92, with an EV/FCF ratio of 20.49.
EV / Earnings | 8.64 |
EV / Sales | 0.94 |
EV / EBITDA | 5.92 |
EV / EBIT | 6.10 |
EV / FCF | 20.49 |
Financial Position
The company has a current ratio of 7.72, with a Debt / Equity ratio of 0.36.
Current Ratio | 7.72 |
Quick Ratio | 0.58 |
Debt / Equity | 0.36 |
Debt / EBITDA | 1.61 |
Debt / FCF | 5.65 |
Interest Coverage | 58.72 |
Financial Efficiency
Return on equity (ROE) is 15.97% and return on invested capital (ROIC) is 10.21%.
Return on Equity (ROE) | 15.97% |
Return on Assets (ROA) | 8.77% |
Return on Invested Capital (ROIC) | 10.21% |
Return on Capital Employed (ROCE) | 15.34% |
Revenue Per Employee | $2.99M |
Profits Per Employee | $323,752 |
Employee Count | 2,800 |
Asset Turnover | 0.91 |
Inventory Turnover | 1.00 |
Taxes
In the past 12 months, TMHC has paid $276.67 million in taxes.
Income Tax | 276.67M |
Effective Tax Rate | 23.33% |
Stock Price Statistics
The stock price has increased by +5.93% in the last 52 weeks. The beta is 1.57, so TMHC's price volatility has been higher than the market average.
Beta (5Y) | 1.57 |
52-Week Price Change | +5.93% |
50-Day Moving Average | 58.01 |
200-Day Moving Average | 63.40 |
Relative Strength Index (RSI) | 55.45 |
Average Volume (20 Days) | 919,929 |
Short Selling Information
The latest short interest is 2.53 million, so 2.52% of the outstanding shares have been sold short.
Short Interest | 2.53M |
Short Previous Month | 2.18M |
Short % of Shares Out | 2.52% |
Short % of Float | 2.54% |
Short Ratio (days to cover) | 2.89 |
Income Statement
In the last 12 months, TMHC had revenue of $8.36 billion and earned $906.51 million in profits. Earnings per share was $8.60.
Revenue | 8.36B |
Gross Profit | 2.06B |
Operating Income | 1.28B |
Pretax Income | 968.08M |
Net Income | 906.51M |
EBITDA | 1.32B |
EBIT | 1.28B |
Earnings Per Share (EPS) | $8.60 |
Balance Sheet
The company has $377.82 million in cash and $2.16 billion in debt, giving a net cash position of -$1.78 billion or -$17.74 per share.
Cash & Cash Equivalents | 377.82M |
Total Debt | 2.16B |
Net Cash | -1.78B |
Net Cash Per Share | -$17.74 |
Equity (Book Value) | 5.96B |
Book Value Per Share | 59.15 |
Working Capital | 6.84B |
Cash Flow
In the last 12 months, operating cash flow was $418.05 million and capital expenditures -$35.73 million, giving a free cash flow of $382.32 million.
Operating Cash Flow | 418.05M |
Capital Expenditures | -35.73M |
Free Cash Flow | 382.32M |
FCF Per Share | $3.81 |
Margins
Gross margin is 24.63%, with operating and profit margins of 15.35% and 10.84%.
Gross Margin | 24.63% |
Operating Margin | 15.35% |
Pretax Margin | 14.18% |
Profit Margin | 10.84% |
EBITDA Margin | 15.82% |
EBIT Margin | 15.35% |
FCF Margin | 4.57% |
Dividends & Yields
TMHC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 3.93% |
Shareholder Yield | 3.93% |
Earnings Yield | 14.98% |
FCF Yield | 6.32% |
Analyst Forecast
The average price target for TMHC is $75.63, which is 25.91% higher than the current price. The consensus rating is "Buy".
Price Target | $75.63 |
Price Target Difference | 25.91% |
Analyst Consensus | Buy |
Analyst Count | 8 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
TMHC has an Altman Z-Score of 4.05 and a Piotroski F-Score of 6.
Altman Z-Score | 4.05 |
Piotroski F-Score | 6 |